Hindustan Unilever Ltd Q1 FY27 Earnings Analysis
Published 3 Jul 2026 | Diversified FMCG | Market Cap: ₹5.3L Cr
Price
₹2,174
Market Cap
₹5.3L Cr
P/E Ratio
48.9
Revenue Rank
Margin Rank
Earnings Summary
- Confident of better FY'27 performance than FY'26, expecting continued revenue growth driven by volume (Page 13, 22, 31). - Focus on competitive volume-led growth as top priority (Pages 13, 22). - Expect to navigate volatile input costs through pricing actions (2%-5% increases taken) and cost savings, maintaining EBITDA margins within guided band of 22.5%-23.5% (Pages 13, 21, 31). - Double-digit growth targeted in premium and growth portfolios such as Beauty & Wellbeing (Masstige portfolio at Rs. - FY’27 outlook is positive with confidence in better performance than FY’26. - Topline growth expected, driven by volume-led growth and ongoing portfolio transformation. - Pricing actions (2-5% increases so far) will continue to manage cost inflation while balancing volume growth. - EBITDA margin guidance maintained in the band of 22.5% to 23.5%, with operating leverage and cost optimization. - Profit After Tax expected to grow, supported by volume growth and operational efficiencies. - Robust balance sheet and strong cash flows support sustainable investments and shareholder returns. - Key growth drivers include premiumization in Personal Care, expansion in Beauty & Wellbeing (e.g., Minimalist at Rs.
📊 Revenue & Sales Performance
Rank 4- Confident of better FY'27 performance than FY'26, expecting continued revenue growth driven by volume (Page 13, 22, 31). - Focus on competitive volume-led growth as top priority (Pages 13, 22). - Expect to navigate volatile input costs through pricing actions (2%-5% increases taken) and cost savings, maintaining EBITDA margins within guided band of 22.5%-23.5% (Pages 13, 21, 31). - Double-digit growth targeted in premium and growth portfolios such as Beauty & Wellbeing (Masstige portfolio at Rs. 1,200 crores ARR), Personal Care premium products, Home Care liquids, and Lifestyle Nutrition (Pages 7, 8, 10, 15). - Expansion in penetration of niche formats in Skin Care (sunscreens, light moisturizers, face washes) and new segments like RTD and protein in Lifestyle Nutrition (Pages 29, 16). - Omnichannel and Quick Commerce capabilities are being scaled up to support growth (Pages 7, 21, 28). - Continuous portfolio premiumization and market development to sustain volume gains (Pages 16, 29).
📈 Profitability & Margins
Rank 3- FY’27 outlook is positive with confidence in better performance than FY’26. - Topline growth expected, driven by volume-led growth and ongoing portfolio transformation. - Pricing actions (2-5% increases so far) will continue to manage cost inflation while balancing volume growth. - EBITDA margin guidance maintained in the band of 22.5% to 23.5%, with operating leverage and cost optimization. - Profit After Tax expected to grow, supported by volume growth and operational efficiencies. - Robust balance sheet and strong cash flows support sustainable investments and shareholder returns. - Key growth drivers include premiumization in Personal Care, expansion in Beauty & Wellbeing (e.g., Minimalist at Rs. 850 cr ARR), and market development in Home Care liquids and Lifestyle Nutrition. - Focus on omni-channel execution, especially Quick Commerce and general trade, to capture evolving consumer behavior. - No specific EPS guidance disclosed, but operational confidence indicates improved earnings per share.
🏗️ Capital Expenditure Plans
Yes- Hindustan Unilever Limited has planned a **Rs. 2,000 crores capital expenditure** focused on expanding capacity in **premium formats** across Home Care, Personal Care, and Beauty categories. - The company has deployed **Rs. 3,500 crores into bolt-on acquisitions** to strengthen its presence in fast-evolving demand spaces, including digital-first premium Beauty & Wellbeing platforms like Minimalist and OZiva. - The strategic investments reflect HUL's focus on **building businesses of the future**, emphasizing portfolio premiumization and growth acceleration. - The capex and acquisitions are part of HUL's sharpened capital allocation to simultaneously **fuel growth and sustain strong shareholder returns**.
💰 Fundraising & Capital Structure
No information- Hindustan Unilever Limited (HUL) has not indicated any new fundraising through debt or equity in the March Quarter & Financial Year 2026 earnings call transcript. - The company has focused on capital allocation by deploying Rs. 3,500 crores into bolt-on acquisitions and signing off on Rs. 2,000 crores planned capex investment for premium formats expansion. - HUL's robust financial position includes total reserves of close to Rs. 49,000 crores and strong cash flow from operations around Rs. 10,500 crores. - The company is directing capital toward growth opportunities and maintaining sustainable shareholder returns. - No explicit mention of raising new debt or equity was made during the call. The financial strategy stresses using existing resources for investments and acquisitions.
📋 Order Book & Pipeline
No informationThe provided pages from the Hindustan Unilever Limited March Quarter & Financial Year 2026 Earnings Call transcript do not contain specific information related to the company's current or expected order book or pending orders. The discussion primarily covers: - Market share and volume growth in product categories like Bodywash and Tea. - Commodity price inflation and pricing strategy amidst cost pressures. - Investments in Go-To-Market capabilities including Quick Commerce and premium formats. - Margin guidance and handling of input cost volatility. - Strategic capital allocation toward bolt-on acquisitions and capacity expansion. - Market development, premiumization, omni-channel approach, and brand building. There is no explicit mention of order book size, pending orders, or related backlog metrics in the provided document excerpts.
Key Metrics
Revenue
Margin
Capex
Fundraise
Order Book
Frequently Asked Questions
What were Hindustan Unilever Ltd Q1 FY27 results?
- Confident of better FY'27 performance than FY'26, expecting continued revenue growth driven by volume (Page 13, 22, 31). - Focus on competitive volume-led growth as top priority (Pages 13, 22). - Expect to navigate volatile input costs through pricing actions (2%-5% increases taken) and cost savings, maintaining EBITDA margins within guided band of 22.5%-23.5% (Pages 13, 21, 31). - Double-digit growth targeted in premium and growth portfolios such as Beauty & Wellbeing (Masstige portfolio at Rs. - FY’27 outlook is positive with confidence in better performance than FY’26. - Topline growth expected, driven by volume-led growth and ongoing portfolio transformation. - Pricing actions (2-5% increases so far) will continue to manage cost inflation while balancing volume growth. - EBITDA margin guidance maintained in the band of 22.5% to 23.5%, with operating leverage and cost optimization. - Profit After Tax expected to grow, supported by volume growth and operational efficiencies. - Robust balance sheet and strong cash flows support sustainable investments and shareholder returns. - Key growth drivers include premiumization in Personal Care, expansion in Beauty & Wellbeing (e.g., Minimalist at Rs.
What is Hindustan Unilever Ltd share price analysis?
Hindustan Unilever Ltd currently shows a neutral. The stock trades at a P/E of 48.9 with a market cap of ₹533,874. Investors should review the full earnings analysis for detailed insights.
Is Hindustan Unilever Ltd planning capital expenditure?
- Hindustan Unilever Limited has planned a **Rs.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
